When looking for the best dividend stocks, it's usually best to not chase the highest dividend. Looking for quality dividend stocks with decent yields is usually a better recipe for large overall returns. Capital appreciation combined with a dividend can produce outsized returns.
Here are my top two picks for big pharma dividend stocks.
An oldie, but goodie
Technically,�Johnson & Johnson (NYSE: JNJ ) isn't a pure pharma since it also sells medical devices and consumer health products, but it's that diversity that makes it such a stable dividend stock.
The company has a history of raising its dividend for more than half a decade. In April, Johnson & Johnson announced an 8.2% increase of its dividend, the 51st�consecutive increase.
AbbVie (NYSE: ABT ) is the only pure pharma in the Dividend Aristocrats club, which requires 25 consecutive years of dividend increases. The six-month-old company is in the index because it spun out of Abbott Labs (NYSE: ABT ) , which was in the index before the split. Even Abbott technically cut its dividend because it lost a substantial amount of its cash flow from AbbVie's drug. Still, I think the S&P let them stay in the index�simply because there are so few health care companies in the Dividend Aristocrats.
Top 10 Clean Energy Companies To Buy Right Now: Cedar Mountain Exploration Inc (CED.V)
Graphite One Resources Inc., a mineral exploration company, engages in the identification, acquisition, and exploration of mineral properties. The company primarily explores for graphite deposits. It owns an option to earn 100% interest in the Graphite Creek Property that consists of 72 claims covering 3,108 hectares and is located to the north of Nome on the Seward Peninsula of Alaska. The company was formerly known as Cedar Mountain Exploration Inc. and changed its name to Graphite One Resources Inc. in March 2012. Graphite One Resources Inc. was founded in 2006 and is based in Vancouver, Canada.
Top 10 Clean Energy Companies To Buy Right Now: Hays(HAS.L)
Hays plc operates as a specialist recruitment company. It provides temporary and permanent placement recruitment services, including qualified, professional, and skilled recruitment to public- and private-sector markets. The company specializes in various areas, including accountancy and finance, construction and property, information technology, life sciences, sales and marketing, banking and capital markets, contact centers, education, engineering and manufacturing, executive, financial services, health and social care, human resources, legal, energy, oil and gas, office professionals, retail, purchasing, resources and mining, and telecom industries. It has operations in the United Kingdom, the Asia Pacific, continental Europe, and Latin America. Hays plc is based in London, the United Kingdom.
10 Best Penny Stocks To Own Right Now: Sina Corporation(SINA)
SINA Corporation provides online media and mobile value-added services (MVAS) in the People?s Republic of China. It provides advertising, non-advertising, and free services through SINA.com, Weibo.com, and SINA Mobile. SINA.com offers free interest-based channels that provide region-focused format and content, including news, sports, automobile-related news, finance, entertainment, luxury, technology, digital, tools, collectibles, video, music, and wireless application protocol, as well as interactive platform for fashion-conscious users to share comments and ideas on a range of topics, such as health, cosmetics, and beauty. The company's microblogging platform, Weibo.com, enables its users to follow the hottest topics being discussed online, as well as discussions related to people they know. Weibo accounts consist of celebrities, commercial enterprises, government entities, and grass root Internet users. Its SINA Mobile service allows users to receive news and informatio n, download ring tones, mobile games and pictures, and participate in dating and friendship communities. The company also offers SINA Game, which serves as an interactive platform that provides users with downloads and gateway access to popular online games; SINA eReading, a shop for book reviews; SINA.net, an enterprise solutions platform to assist businesses and government bodies; and SINA Mall, an online shopping Website. In addition, it provides a platform for Chinese bloggers; photo-sharing platform; free email, VIP mail, and corporate email for enterprise users; audio and video-based instant messaging tools; proprietary search technology; and classified advertising services, as well as hosts topic-specific discussion forums in Chinese language; and creates user-maintained and supported online communities. The company has strategic cooperation agreement with China Unicom (Hong Kong) Limited. SINA Corporation was founded in 1997 and is headquartered in Shanghai, the Peop le?s Republic of China.
Top 10 Clean Energy Companies To Buy Right Now: Cofide(COFI.MI)
COFIDE - Gruppo De Benedetti S.p.A., through its subsidiaries, operates in utilities, media, automotive components, healthcare, and financial services sectors primarily in Italy, rest of Europe, North America, South America, and Asia. In the utilities sector, the company engages in the generation of electricity through combined cycle gas turbine, as well as renewable resources comprising wind, photovoltaic, and biomass plants; and ownership of hydrocarbon licenses in North Sea, Bulgaria, and Colombia. It operates an installed capacity of approximately 3,800 megawatts. In the media sector, the company is involved in publishing daily newspaper la Repubblica and a weekly magazine L?Espresso, as well as 16 local daily newspapers; broadcasting 3 national radio stations Radio Deejay, Radio Capital, and Radio m2o; operating a television network and an Internet Website; and collecting advertising for third-party publications. In the automotive components sector, it produces filte rs and suspension components for the original equipment market, and the original and independent replacement market. In the healthcare sector, the company operates nursing homes under the Anni Azzurri; rehabilitation centers under Santo Stefano and Redancia brands; and hospital facilities under Medipass brand, as well as the Fratelli Montecchi hospital in Suzzara. In the financial services sector, it engages in the provision of lifetime mortgages and non-performing loans; management of venture capital funds; and investments in private equity funds. The company was founded in 1976 and is headquartered in Milano, Italy. COFIDE - Gruppo De Benedetti S.p.A. operates as a subsidiary of Carlo De Benedetti & Figli S.a.p.A.
Top 10 Clean Energy Companies To Buy Right Now: Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company�� product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company's program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company's RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company's lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company's lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatment of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company's lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
Anti-Viral Programs
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company's arrangement with DoD supporting the development of the Company's Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrangement. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company's anti-viral therapeutic programs use the Company's translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company's translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA's Animal Rule. The Company's lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company's lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD's invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exposure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
Influenza Program
The Company's anti-viral therapeutic programs are also focused on the development of the Company's product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company's lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company's PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
Advisors' Opinion:- [By TheStreet Staff]
Sarepta Therapeutics (SRPT) will have another big year, with an accelerated approval filing mid-year for the Duchenne muscular dystrophy drug eteplirsen in the U.S. and a significant and lucrative ex-U.S. partnership for the company's exon-skipping drug technology platform.
Top 10 Clean Energy Companies To Buy Right Now: It Way Spa(ITW.MI)
Itway S.p.A. engages in the distribution and integration of software and hardware products for the logical security of information systems primarily in Italy, France, the Iberian Peninsula, Greece, and Turkey. The company offers consultancy services and system integration services, as well as produces solutions and software technologies for e-businesses. Its services also include training and supporting companies in the areas of e-business, e-security, central access management, internetworking and wireless. In addition, the company offers specialized certification services on software technologies and pre- and post-sale technical assistance services. Itway S.p.A. is headquartered in Ravenna, Italy.
Top 10 Clean Energy Companies To Buy Right Now: Cohu Inc.(COHU)
Cohu, Inc. engages in the development, manufacture, sale, and servicing of test handling and burn-in related equipment, and thermal sub-systems for the semiconductor industry worldwide. The company operates in three segments: Semiconductor Equipment, Microwave Communication Systems, and Video Cameras. The Semiconductor Equipment segment develops, manufactures, and sells pick-and-place semiconductor test handlers, burn-in related equipment, and thermal sub-systems to semiconductor manufacturers and semiconductor test subcontractors. It also develops, manufactures, and sells gravity-feed and test-in-strip semiconductor test handling equipment used in final test operations. The Microwave Communication Systems segment develops, manufactures, and sells microwave communications equipment, antenna systems, and associated equipment, which are used in the transmission of video, audio, and telemetry. These products have applications in unmanned aerial vehicles, law enforcement, secu rity and surveillance, and electronic news gathering. Its customers include government agencies, law enforcement and public safety organizations, unmanned air vehicle program contractors, television broadcasters, entertainment companies, professional sports teams, and other commercial entities. The Video Cameras segment develops, manufactures, and sells closed circuit video or CCTV cameras, equipment, and systems for security, surveillance, and traffic monitoring. It also offers accessories, which include monitors, lenses, and camera test equipment. This segment serves end-users, government agencies, original equipment manufacturers, contractors, and value-added resellers. Cohu, Inc. markets its products through direct sales force and independent sales representatives. The company was formerly known as Cohu Electronics, Inc. and changed its name to Cohu, Inc. in 1972. Cohu, Inc. was founded in 1947 and is based in Poway, California.
Top 10 Clean Energy Companies To Buy Right Now: Ethos Capital Corp(ECC.V)
Ethos Gold Corp. engages in the identification, exploration, and development of mineral properties in Mexico and Canada. It explores for silver, lead, zinc, copper, and gold, as well as vanadium and gallium properties. The company has a property portfolio comprising 4,963 claims covering 103,857 hectares located in the White gold district, Yukon. Its principle properties include Hayes, Wolf, Betty, Bridget, Hen, and Rude Creek in the White gold district; and Santa Teresa and Corrales properties in Mexico. The company was formerly known as Capital Corp. and changed its name to Ethos Gold Corp. in April 2012. Ethos Gold Corp. was incorporated in 2007 and is based in Vancouver, Canada.
Top 10 Clean Energy Companies To Buy Right Now: Riverstone Resources Inc.(RVS.V)
Riverstone Resources Inc., an exploration-stage company, engages in the acquisition, exploration, and development of mineral resource properties in Burkina Faso, West Africa. The company primarily explores for gold. Its principal project is the Karma project that consists of six contiguous permits in Goulagou, Rounga, Youba, Tougou, Kao, and Rambo deposits located in the north-central part of Burkina Faso. The company is headquartered in Vancouver, Canada.
Top 10 Clean Energy Companies To Buy Right Now: Orion Marine Group Inc(ORN)
Orion Marine Group, Inc. operates as a marine specialty contractor serving the heavy civil marine infrastructure market. The company provides a range of marine construction and specialty services on, over, and under the water along the Gulf Coast, the Atlantic Seaboard, the West Coast, Canada, the Caribbean Basin, and the Pacific Northwest. The company?s marine construction services include construction of marine transportation facilities, marine pipelines, bridges and causeways, and marine environmental structures. Its marine transportation facility construction projects comprise public port facilities for container ship loading and unloading; cruise ship port facilities; private terminals; recreational use marinas and docks; and other marine-based facilities. Orion Marine Group?s marine pipeline service projects consist of the installation and removal of underwater buried pipeline transmission lines; installation of pipeline intakes and outfalls for industrial facilities ; construction of pipeline outfalls for wastewater and industrial discharges; river crossing and directional drilling; and creation of hot taps and tie-ins. Its bridge and causeway projects include the construction, repair, and maintenance of bridges and causeways, as well as the development of fendering systems in marine environments; and marine environmental structure projects primarily comprise the installation of concrete mattresses to ensure erosion protection, and the installation of geotubes for wetlands and island creation. In addition, the company offers dredging services; specialty services, including salvage, demolition, surveying, towing, diving and underwater inspection, excavation, and repair; and survey services comprising surveying pipelines and performing hydrographic surveys. Its customers include federal, state, and municipal governments, as well as private commercial and industrial enterprises. The company was founded in 1994 and is headquartered in Houst on, Texas.
No comments:
Post a Comment